Takeda Pharmaceutical Company Limited
Prevention and reduction of blood loss

Last updated:

Abstract:

Methods are described for preventing or reducing ischemia and/or systemic inflammatory response in a patient such as perioperative blood loss and/or systemic inflammatory response in a patient subjected to cardiothoracic surgery, e.g. coronary artery bypass grafting and other surgical procedures, especially when such procedures involve extra-corporeal circulation, such as cardiopulmonary bypass.

Status:
Grant
Type:

Utility

Filling date:

21 Feb 2019

Issue date:

31 May 2022